Outcome of Burkholderia cepacia colonisation in an adult cystic fibrosis centre.

PubWeight™: 1.08‹?› | Rank: Top 10%

🔗 View Article (PMC 1746259)

Published in Thorax on February 01, 2002

Authors

M J Ledson1, M J Gallagher, M Jackson, C A Hart, M J Walshaw

Author Affiliations

1: Regional Adult Cystic Fibrosis Unit, The Cardiothoracic Centre, Liverpool L14 3PE, UK.

Articles citing this

Clinical significance of microbial infection and adaptation in cystic fibrosis. Clin Microbiol Rev (2011) 2.23

Autophagy stimulation by rapamycin suppresses lung inflammation and infection by Burkholderia cenocepacia in a model of cystic fibrosis. Autophagy (2011) 2.06

Comparative assessment of genotyping methods for epidemiologic study of Burkholderia cepacia genomovar III. J Clin Microbiol (2002) 1.79

Involvement of a plasmid-encoded type IV secretion system in the plant tissue watersoaking phenotype of Burkholderia cenocepacia. J Bacteriol (2004) 1.40

Risk factors for death of patients with cystic fibrosis awaiting lung transplantation. Am J Respir Crit Care Med (2005) 1.30

Burkholderia cenocepacia C5424 produces a pigment with antioxidant properties using a homogentisate intermediate. J Bacteriol (2007) 1.13

Role of bacteriocins in mediating interactions of bacterial isolates taken from cystic fibrosis patients. Microbiology (2010) 1.07

Genomovar diversity amongst Burkholderia cepacia complex isolates from an Australian adult cystic fibrosis unit. Eur J Clin Microbiol Infect Dis (2003) 1.00

A type IV secretion system contributes to intracellular survival and replication of Burkholderia cenocepacia. Infect Immun (2008) 0.97

Burkholderia cenocepacia ET12 strain activates TNFR1 signalling in cystic fibrosis airway epithelial cells. Cell Microbiol (2007) 0.97

Susceptibility of Caenorhabditis elegans to Burkholderia infection depends on prior diet and secreted bacterial attractants. PLoS One (2009) 0.94

Clinical applications of pulmonary delivery of antibiotics. Adv Drug Deliv Rev (2014) 0.93

Regulation and functional significance of autophagy in respiratory cell biology and disease. Am J Respir Cell Mol Biol (2012) 0.89

Host evasion by Burkholderia cenocepacia. Front Cell Infect Microbiol (2012) 0.82

Organisms isolated from adults with cystic fibrosis. Ann Clin Microbiol Antimicrob (2004) 0.81

Characterization of BCAM0224, a multifunctional trimeric autotransporter from the human pathogen Burkholderia cenocepacia. J Bacteriol (2014) 0.80

Changes in structural lung disease in cystic fibrosis children over 4 years as evaluated by high-resolution computed tomography. Eur Radiol (2015) 0.78

Lung transplantation for cystic fibrosis: results, indications, complications, and controversies. Semin Respir Crit Care Med (2015) 0.76

Two case reports of the successful eradication of new isolates of Burkholderia cepacia complex in children with cystic fibrosis. BMC Pharmacol Toxicol (2016) 0.75

Physiotherapy for cystic fibrosis in Australia and New Zealand: A clinical practice guideline. Respirology (2016) 0.75

Burkholderia cepacia complex in Serbian patients with cystic fibrosis: prevalence and molecular epidemiology. Eur J Clin Microbiol Infect Dis (2016) 0.75

Articles cited by this

Analysis of serial measurements in medical research. BMJ (1990) 16.69

Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol Rev (1996) 13.91

Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J Pediatr (1984) 9.61

Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis. Lancet (1993) 7.12

Cystic fibrosis: current survival and population estimates to the year 2000. Thorax (1991) 7.12

Pseudomonas cepacia colonization in patients with cystic fibrosis: risk factors and clinical outcome. J Pediatr (1985) 4.26

Burkholderia cepacia: medical, taxonomic and ecological issues. J Med Microbiol (1996) 4.11

Pseudomonas cepacia colonization among patients with cystic fibrosis. A new opportunist. Am Rev Respir Dis (1985) 3.71

Bronchoalveolar lavage or oropharyngeal cultures to identify lower respiratory pathogens in infants with cystic fibrosis. Pediatr Pulmonol (1996) 3.49

Burkholderia cepacia. Management issues and new insights. Clin Chest Med (1998) 3.23

Frequent antibiotic therapy improves survival of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection. Acta Paediatr Scand (1983) 3.13

Mucoid Pseudomonas aeruginosa is a marker of poor survival in cystic fibrosis. Pediatr Pulmonol (1992) 3.00

Colonization and infection with Pseudomonas cepacia. J Infect Dis (1972) 2.91

Gender gap in cystic fibrosis mortality. Am J Epidemiol (1997) 2.74

Determinants of mortality from cystic fibrosis in Canada, 1970-1989. Am J Epidemiol (1996) 2.28

Clinical outcome in relation to care in centres specialising in cystic fibrosis: cross sectional study. BMJ (1998) 2.22

Chronic Burkholderia cepacia bronchiectasis in a non-cystic fibrosis individual. Thorax (1998) 2.20

Five- to seven-year course of pulmonary function in cystic fibrosis. Am Rev Respir Dis (1976) 2.03

Screening for cystic fibrosis; public policy and personal choices. N Engl J Med (1990) 1.97

Outcome of Burkholderia (Pseudomonas) cepacia colonisation in children with cystic fibrosis following a hospital outbreak. Thorax (1995) 1.78

Effect of Pseudomonas cepacia colonization on survival and pulmonary function of cystic fibrosis patients. J Clin Epidemiol (1990) 1.69

Type characterisation and antibiotic susceptibility of Burkholderia (Pseudomonas) cepacia isolates from patients with cystic fibrosis in the United Kingdom and the Republic of Ireland. J Med Microbiol (1996) 1.60

Cross infection between cystic fibrosis patients colonised with Burkholderia cepacia. Thorax (1998) 1.50

Outcome for patients colonised with Burkholderia cepacia in a Birmingham adult cystic fibrosis clinic and the end of an epidemic. Thorax (1996) 1.29

Burkholderia (Pseudomonas) cepacia and cystic fibrosis: the epidemiology in Belgium. Acta Clin Belg (1996) 1.20

Occurrence of nonfermentative gram-negative rods other than Pseudomonas aeruginosa in the respiratory tract of children with cystic fibrosis. Helv Paediatr Acta (1982) 1.18

Improvement of nutritional status and lung function after long-term nocturnal gastrostomy feedings in cystic fibrosis. J Pediatr (1994) 1.13

Pseudomonas cepacia: pulmonary infection in patients with cystic fibrosis. Respir Med (1993) 1.09

Pulmonary evolution of cystic fibrosis patients colonized by Pseudomonas aeruginosa and/or Burkholderia cepacia. Eur J Pediatr (1998) 0.99

Sputum bacteriology in patients with cystic fibrosis in a Toronto hospital during 1970-1981. J Infect Dis (1984) 0.99

Respiratory tract colonization with Pseudomonas aeruginosa in cystic fibrosis: correlations between anti-Pseudomonas aeruginosa antibody levels and pulmonary function. Pediatr Pulmonol (1991) 0.96

Predicting survival in cystic fibrosis. Thorax (1997) 0.93

Should patients with cystic fibrosis infected with Burkholderia cepacia undergo lung transplantation? Thorax (1997) 0.82

Articles by these authors

Cephamycins, a new family of beta-lactam antibiotics. I. Production by actinomycetes, including Streptomyces lactamdurans sp. n. Antimicrob Agents Chemother (1972) 5.23

Efficient allelic exchange and transposon mutagenesis in Mycobacterium tuberculosis. Proc Natl Acad Sci U S A (1997) 4.93

Reproductive tract infections and abortion among adolescent girls in rural Nigeria. Lancet (1995) 4.86

Thienamycin, a new beta-lactam antibiotic. I. Discovery, taxonomy, isolation and physical properties. J Antibiot (Tokyo) (1979) 4.82

Mutants of yeast defective in iso-1-cytochrome c. Genetics (1974) 4.73

Short cytoplasmic sequences serve as retention signals for transmembrane proteins in the endoplasmic reticulum. Cell (1989) 4.47

Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic. Lancet (1996) 4.07

Phosphonomycin, a new antibiotic produced by strains of streptomyces. Science (1969) 3.89

Superinfection with a transmissible strain of Pseudomonas aeruginosa in adults with cystic fibrosis chronically colonised by P aeruginosa. Lancet (2001) 3.49

A deletion map of cyc1 mutants and its correspondence to mutationally altered iso-1-cytochromes c of yeast. Genetics (1975) 3.48

Validation of the Glasgow Meningococcal Septicemia Prognostic Score: a 10-year retrospective survey. Crit Care Med (1991) 3.29

Antibiotic resistance found in wild rodents. Nature (1999) 3.20

Potassium channel antibodies in two patients with reversible limbic encephalitis. Ann Neurol (2001) 3.06

Mortality in severe meningococcal disease. Arch Dis Child (2001) 3.03

Social deprivation and prognostic benefits of cardiac surgery: observational study of 44 902 patients from five hospitals over 10 years. BMJ (2009) 2.95

Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: report of Radiation Therapy Oncology Group Protocol 85-31. J Clin Oncol (1997) 2.75

Mapping and gene conversion studies with the structural gene for iso-1-cytochrome C in yeast. Genetics (1975) 2.65

Identification and mutational relocation of the AUG codon initiating translation of iso-1-cytochrome c in yeast. J Biol Chem (1971) 2.57

Bacterial diversity in cases of lung infection in cystic fibrosis patients: 16S ribosomal DNA (rDNA) length heterogeneity PCR and 16S rDNA terminal restriction fragment length polymorphism profiling. J Clin Microbiol (2003) 2.56

Molecular characterization of a novel plasmid-encoded cefotaximase (CTX-M-12) found in clinical Klebsiella pneumoniae isolates from Kenya. Antimicrob Agents Chemother (2001) 2.39

Kinetics and affinity of reactions between an antigen-specific T cell receptor and peptide-MHC complexes. Immunity (1994) 2.39

Rotavirus G and P types in children with acute diarrhea in Blantyre, Malawi, from 1997 to 1998: predominance of novel P[6]G8 strains. J Med Virol (1999) 2.33

Nontyphoidal Salmonella infections of children in tropical Africa. Pediatr Infect Dis J (2000) 2.32

Clinical presentation and outcome of Pneumocystis carinii pneumonia in Malawian children. Lancet (2000) 2.28

Vulvovaginitis: causes and management. Arch Dis Child (1992) 2.28

Chronic Burkholderia cepacia bronchiectasis in a non-cystic fibrosis individual. Thorax (1998) 2.20

Who spots the spots? Diagnosis and treatment of early meningococcal disease in children. BMJ (1996) 2.20

Results of balloon pulmonary valvuloplasty as a palliative procedure in tetralogy of Fallot. J Am Coll Cardiol (1991) 2.10

High-affinity reactions between antigen-specific T-cell receptors and peptides associated with allogeneic and syngeneic major histocompatibility complex class I proteins. Proc Natl Acad Sci U S A (1994) 2.09

Cardiac arrest during intramedullary nailing for femoral metastases. J Bone Joint Surg Br (1993) 2.07

Acute pain after thoracic surgery predicts long-term post-thoracotomy pain. Clin J Pain (1996) 2.05

Neuroaxial blockade and psoriasis. Int J Obstet Anesth (2007) 2.03

RCPE UK consensus statement on diabetes. J R Coll Physicians Edinb (2010) 2.03

Human cryptosporidiosis: a possible case of hospital cross infection. Br Med J (Clin Res Ed) (1983) 2.02

Updating the nurse's bedside manner. Image J Nurs Sch (1993) 2.02

Antibiotic resistance: an increasing problem?. It always has been, but there are things we can do. BMJ (1998) 2.00

Organization and expression of non-Alu family interspersed repetitive DNA sequences in the mouse genome. J Mol Biol (1984) 1.96

Does breastfeeding method influence infant weight gain? Arch Dis Child (2007) 1.94

Benzydamine HCl for prophylaxis of radiation-induced oral mucositis: results from a multicenter, randomized, double-blind, placebo-controlled clinical trial. Cancer (2001) 1.91

Cell wall core galactofuran synthesis is essential for growth of mycobacteria. J Bacteriol (2001) 1.90

Increased prevalence of malaria in HIV-infected pregnant women and its implications for malaria control. Trop Med Int Health (1999) 1.90

Platelet-derived growth factor-modulated proteins: constitutive synthesis by a transformed cell line. Proc Natl Acad Sci U S A (1981) 1.90

Human herpesviruses in the cornea. Br J Ophthalmol (2000) 1.90

Mcl-1 expression in human neutrophils: regulation by cytokines and correlation with cell survival. Blood (1998) 1.89

Cellular response to modulated radiation fields. Phys Med Biol (2007) 1.88

Tiacumicins, a novel complex of 18-membered macrolide antibiotics. I. Taxonomy, fermentation and antibacterial activity. J Antibiot (Tokyo) (1987) 1.87

Efficacy of D0870 compared with those of itraconazole and amphotericin B in two murine models of invasive aspergillosis. Antimicrob Agents Chemother (1995) 1.86

Hantaviruses. J Med Microbiol (2000) 1.86

The prevalence of enteric pathogens in diarrhoeic thoroughbred foals in Britain and Ireland. Equine Vet J (1991) 1.76

Genotype analysis of Escherichia coli strains isolated from children and chickens living in close contact. Appl Environ Microbiol (1999) 1.73

The development and performance of a simple, sensitive method for the detection of Cryptosporidium oocysts in faeces. J Hyg (Lond) (1984) 1.73

Epidemiology of rotavirus diarrhoea in Africa: a review to assess the need for rotavirus immunization. Bull World Health Organ (1998) 1.72

A redrawn Vandenberg and Kuse mental rotations test: different versions and factors that affect performance. Brain Cogn (1995) 1.71

Severe hypophosphatemia in children with kwashiorkor is associated with increased mortality. J Pediatr (1998) 1.70

Isolation from Klebsiella and characterization of two rcs genes that activate colanic acid capsular biosynthesis in Escherichia coli. J Gen Microbiol (1987) 1.70

Procalcitonin as a diagnostic marker of meningococcal disease in children presenting with fever and a rash. Arch Dis Child (2002) 1.69

Rotavirus strain diversity in Blantyre, Malawi, from 1997 to 1999. J Clin Microbiol (2001) 1.68

Effect of concomitant HIV infection on presentation and outcome of rotavirus gastroenteritis in Malawian children. Lancet (2001) 1.67

Prevalence of infection with hepatitis B and C virus and coinfection with HIV in medical inpatients in Malawi. J Infect (2008) 1.66

Demonstration of the UAA ochre codon in bakers yeast by amino-acid replacements in iso-1-cytochrome c. J Mol Biol (1972) 1.66

B cells are exquisitely sensitive to central tolerance and receptor editing induced by ultralow affinity, membrane-bound antigen. J Exp Med (1996) 1.66

Features and outcome in meningococcal disease presenting with maculopapular rash. Arch Dis Child (1991) 1.65

Effect of respiratory virus infections including rhinovirus on clinical status in cystic fibrosis. Arch Dis Child (1995) 1.65

Meningococcal bacterial DNA load at presentation correlates with disease severity. Arch Dis Child (2002) 1.64

Determinants of chemotactic signal amplification in Escherichia coli. J Mol Biol (2001) 1.64

Multi-drug resistant typhoid: a global problem. J Med Microbiol (1996) 1.64

Limitations of the Parsonnet score for measuring risk stratified mortality in the north west of England. The North West Regional Cardiac Surgery Audit Steering Group. Heart (2000) 1.63

Placental transfer and maternally acquired neonatal IgG immunity in human immunodeficiency virus infection. J Infect Dis (1996) 1.63

Arithmetic skills in patients with unilateral cerebral lesions. Cortex (1986) 1.63

Particles with properties of retroviruses in monocytes from patients with breast cancer. Lancet (1988) 1.62

Increased morbidity associated with chronic infection by an epidemic Pseudomonas aeruginosa strain in CF patients. Thorax (2004) 1.62

Age is not an impediment to effective use of patient-controlled analgesia by surgical patients. Anesthesiology (2000) 1.62

Prevalence and transmission of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in Ugandan children and adolescents. Int J Cancer (1998) 1.61

Tyrosine substitutions resulting from suppression of amber mutants of iso-1-cytochrome c in yeast. J Mol Biol (1973) 1.59

Bovine digital dermatitis and severe virulent ovine foot rot: a common spirochaetal pathogenesis. Vet J (2005) 1.59

Tau, ubiquitin, and alpha B-crystallin immunohistochemistry define the principal causes of degenerative frontotemporal dementia. Arch Neurol (1995) 1.59

Congenital testicular maldescent: significance of the complete hernial sac. Br J Urol (1995) 1.56

The rapid identification of "normal" parathyroid glands by the presence of intracellular fat. Am J Pathol (1976) 1.55

Procalcitonin as a marker of sepsis. Int J Antimicrob Agents (2002) 1.52

Molecular epidemiology of rotavirus diarrhea among children and adults in Nepal: detection of G12 strains with P[6] or P[8] and a G11P[25] strain. J Clin Microbiol (2006) 1.51

Recombinant TGF-beta 1 is synthesized as a two-component latent complex that shares some structural features with the native platelet latent TGF-beta 1 complex. Growth Factors (1989) 1.51

Prophylactic treatment of anthrax with antibiotics. BMJ (2001) 1.51

Antibody to streptococcal cell wall peptidoglycan-polysaccharide polymers in seropositive and seronegative rheumatic disease. Clin Exp Immunol (1984) 1.50

Ethyl-substituted erythromycin derivatives produced by directed metabolic engineering. Proc Natl Acad Sci U S A (1998) 1.50

Cross infection between cystic fibrosis patients colonised with Burkholderia cepacia. Thorax (1998) 1.50

Analysis of plasmid and chromosomal DNA of multidrug-resistant Salmonella enterica serovar typhi from Asia. J Clin Microbiol (2000) 1.49

Treatment of large airway obstruction in lung cancer using expandable metal stents inserted under direct vision via the fibreoptic bronchoscope. Thorax (1996) 1.49

Reducing the risk of retained throat packs after surgery. Br J Oral Maxillofac Surg (2012) 1.48

Epidermal cancer associated with expression of human papillomavirus type 16 E6 and E7 oncogenes in the skin of transgenic mice. Proc Natl Acad Sci U S A (1993) 1.48

Pulsed-field gel electrophoresis of degradation-sensitive DNAs from Clostridium difficile PCR ribotype 1 strains. J Clin Microbiol (2000) 1.48

Nitric oxide production in meningococcal disease is directly related to disease severity. Crit Care Med (1999) 1.47

Selective decontamination of the digestive tract (SDD) in intensive care patients: a critical evaluation of the clinical, bacteriological and epidemiological benefits. J Hosp Infect (1991) 1.46

Environmental contamination with an epidemic strain of Pseudomonas aeruginosa in a Liverpool cystic fibrosis centre, and study of its survival on dry surfaces. J Hosp Infect (2005) 1.46